NCT01644565View on ClinicalTrials.gov

Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2015

Conditions
Escherichia Coli Infection
Interventions
BIOLOGICAL

Recombinant fimbrial adhesin dsc14CfaE-sCTA2/LTB5

BIOLOGICAL

Recombinant fimbrial adhesin dscCfaE

BIOLOGICAL

Modified E. coli heat labile enterotoxin LTR192G

Trial Locations (1)

20910

Walter Reed Army Institute of Research Clinical trial Center, Silver Spring

All Listed Sponsors
lead

U.S. Army Medical Research and Development Command

FED

NCT01644565 - Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea | Biotech Hunter | Biotech Hunter